Citigroup Maintains Buy on Intuitive Surgical, Raises Price Target to $462
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch has maintained a Buy rating on Intuitive Surgical (NASDAQ:ISRG) and increased the price target from $428 to $462. This adjustment reflects a positive outlook on the company's future performance.
April 03, 2024 | 3:52 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup has reaffirmed its Buy rating on Intuitive Surgical and raised the price target to $462, indicating a positive outlook.
The increase in price target by a reputable analyst like Joanne Wuensch from Citigroup usually signals a strong confidence in the company's future performance and growth potential. This can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100